Hims & Hers responds to controversy over Super Bowl weight loss drug commercial: 'We're calling for change'
Hims & Hers believes that is where the controversy lies. “We called on the industry and said that they need to change — and their reaction is trying to shut this ad down,” says a representative for the company. “To us, it's clear that it's not about the ad — it's about the message.”
The spot makes lofty claims about weight-loss drugs offered by the telehealth company Hims & Hers, but says little about ...
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...
Variety on MSN10d
Hims & Hers Hopes Super Bowl Commercial About Obesity Stands Apart From Pack of SnacksHims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot ...
In today’s world, erectile dysfunction (ED) affects millions of men, causing emotional and psychological distress.
24/7 Wall St. on MSN15h
Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big TodayStock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating ...
Shares of Hims and Hers (NYSE:HIMS) climbed 5% despite facing criticism over a Super Bowl advertisement for its generic weight-loss drugs. The ad, which highlights the company's more affordable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback